826 related articles for article (PubMed ID: 9492054)
41. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
[TBL] [Abstract][Full Text] [Related]
42. Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells.
Wu G; Fan RS; Li W; Ko TC; Brattain MG
Oncogene; 1997 Sep; 15(13):1555-63. PubMed ID: 9380407
[TBL] [Abstract][Full Text] [Related]
43. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
Crowe DL; Shuler CF
Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
[TBL] [Abstract][Full Text] [Related]
44. Unique natural antioxidants (NAOs) and derived purified components inhibit cell cycle progression by downregulation of ppRb and E2F in human PC3 prostate cancer cells.
Bakshi S; Bergman M; Dovrat S; Grossman S
FEBS Lett; 2004 Aug; 573(1-3):31-7. PubMed ID: 15327971
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
46. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
48. Transforming growth factor-beta regulation of retinoblastoma gene product and E2F transcription factor during cell cycle progression in mouse fibroblasts.
Kim TA; Ravitz MJ; Wenner CE
J Cell Physiol; 1994 Jul; 160(1):1-9. PubMed ID: 8021288
[TBL] [Abstract][Full Text] [Related]
49. A model of the G1 phase of the cell cycle incorporating cyclin E/cdk2 complex and retinoblastoma protein.
Obeyesekere MN; Herbert JR; Zimmerman SO
Oncogene; 1995 Sep; 11(6):1199-205. PubMed ID: 7566981
[TBL] [Abstract][Full Text] [Related]
50. IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells.
Hobeika AC; Subramaniam PS; Johnson HM
Oncogene; 1997 Mar; 14(10):1165-70. PubMed ID: 9121765
[TBL] [Abstract][Full Text] [Related]
51. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
52. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
Ruesch MN; Laimins LA
J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
[TBL] [Abstract][Full Text] [Related]
53. Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins.
Yang R; Müller C; Huynh V; Fung YK; Yee AS; Koeffler HP
Mol Cell Biol; 1999 Mar; 19(3):2400-7. PubMed ID: 10022926
[TBL] [Abstract][Full Text] [Related]
54. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
55. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
[TBL] [Abstract][Full Text] [Related]
56. Phenylacetate inhibits growth and modulates cell cycle gene expression in renal cancer cell lines.
Franco OE; Onishi T; Umeda Y; Soga N; Wakita T; Arima K; Yanagawa M; Sugimura Y
Anticancer Res; 2003; 23(2B):1637-42. PubMed ID: 12820434
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of the glioblastoma cell cycle by type I IFNs occurs at both the G1 and S phases and correlates with the upregulation of p21(WAF1/CIP1).
Tanabe T; Kominsky SL; Subramaniam PS; Johnson HM; Torres BA
J Neurooncol; 2000 Jul; 48(3):225-32. PubMed ID: 11100820
[TBL] [Abstract][Full Text] [Related]
58. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein.
Naeger LK; Goodwin EC; Hwang ES; DeFilippis RA; Zhang H; DiMaio D
Cell Growth Differ; 1999 Jun; 10(6):413-22. PubMed ID: 10392903
[TBL] [Abstract][Full Text] [Related]
59. p27Kip1 is the key mediator of phenylacetate induced cell cycle arrest in human prostate cancer cells.
Onishi T; Yamakawa K; Franco OE; Suzuki R; Kawamura J
Anticancer Res; 2000; 20(5A):3075-81. PubMed ID: 11062725
[TBL] [Abstract][Full Text] [Related]
60. Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm.
Yang ES; Burnstein KL
J Biol Chem; 2003 Nov; 278(47):46862-8. PubMed ID: 12954644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
